General - Press Releases

Date	Title	Company
21-Jul-2023	BeiGene Announces Positive CHMP Opinion for Tislelizumab as a Treatment for Advanced or Metastatic ESCC	Businesswire
21-Jul-2023	Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Trastuzumab and Chemotherapy as First-Line Treatment for HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Expressing PD-L1 (CPS ≥1)	Businesswire
21-Jul-2023	Stoke Therapeutics to Host Webinar to Present New Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome	Businesswire
21-Jul-2023	Global Biotin Supplement Market Opportunity Analysis and Forecasts 2021-2022 & 2023-2031: $1.4 Bn Market Set to Soar with Increasing Focus on Hair, Skin, and Nail Care - ResearchAndMarkets.com	Businesswire
21-Jul-2023	Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) as an Adjuvant Treatment for Patients with Completely Resected Stage IIB or IIC Melanoma	Businesswire
21-Jul-2023	Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2023	Businesswire
21-Jul-2023	Toppan Holds VIRTUAL REMIX JAPAN™ Metaverse Event	Toppan
21-Jul-2023	Are shared medical appointments the key to solving global healthcare shortages?	ESMT Berlin
21-Jul-2023	Molecure completes successful Secondary Public Offering (SPO) of approximately PLN 50 million (USD 12 million) with proceeds to be used to fund and build a first in class, sustainable pipeline of breakthrough therapies	Molecure S.A.
21-Jul-2023	Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis	Tillotts Pharma
21-Jul-2023	The Science-Based Targets Initiative (SBTi) validates Almirall's 2030 emission reduction targets and its goal of achieving net zero emissions by 2050	Almirall
21-Jul-2023	Teva UK launches GoResp® Digihaler® (budesonide/ formoterol), the first integrated digital inhaler system for appropriate adult patients with asthma and COPD[i] in the UK	Teva UK Limited
21-Jul-2023	Researchers aim for rapid biomarker diagnostic test for stroke, using saliva	University of Birmingham
21-Jul-2023	HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study	HUTCHMED
21-Jul-2023	Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)	Businesswire
21-Jul-2023	Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a “Strong Buy” Recommendation	Businesswire
21-Jul-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
21-Jul-2023	ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors	Businesswire
21-Jul-2023	Sensient Declares Dividend	Businesswire
20-Jul-2023	Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2023 Financial Results	Businesswire